Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term safety of Caduet in Japanese patients with hypertension/angina and hypercholesterolemia
NCT01190007Phase 4Completed
- Sponsor
- Viatris
- Start
- Aug 2010
- Primary completion
- Feb 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of amlodipine in hypertension (HTN), hypercholesterolemia and angina pectoris, sponsored by Viatris. Primary endpoint: Number of Participants With Adverse Events (AEs) and Serious Adverse Events (SAEs) at 52 weeks. Started Aug 2010; status: completed.
02
Drugs
amlodipine
03
Conditions
hypertension (HTN)hypercholesterolemiaangina pectoris
Beyond the preview
Go deeper on NCT01190007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01190007.